Intraoral administration of probiotics and postbiotics: An overview of microorganisms and formulation strategies

被引:0
|
作者
Bogdanovic, Mihajlo [1 ]
Mladenovic, Dragana [2 ]
Mojovic, Ljiljana [1 ]
Djuris, Jelena [3 ]
Djukic-Vukovic, Aleksandra [1 ,4 ]
机构
[1] Univ Belgrade, Fac Technol & Met, Belgrade, Serbia
[2] Univ Belgrade, Innovat Ctr, Fac Technol & Met, Belgrade, Serbia
[3] Univ Belgrade, Fac Pharm, Belgrade, Serbia
[4] Univ Belgrade, Dept Biochem Engn & Biotechnol, Fac Technol & Met, Karnegijeva 4, Belgrade 11000, Serbia
关键词
Postbiotics; Probiotics; Oral dosage forms; Oral microbiota; Ligilactobacillus salivarius; ANTIBACTERIAL ACTIVITY; BACTERIAL DIVERSITY; ORAL MICROBIOME; DOUBLE-BLIND; HEALTH; EXOPOLYSACCHARIDES; DELIVERY; CAVITY;
D O I
10.1590/s2175-97902024e23272
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The last decade provided significant advances in the understanding of microbiota and its role in human health. Probiotics are live microorganisms with proven benefits for the host and were mostly studied in the context of gut health, but they can also confer significant benefits for oral health, mainly in the treatment of gingivitis. Postbiotics are cell -free extracts and metabolites of microorganisms which can provide additional preventive and therapeutic value for human health. This opens opportunities for new preventive or therapeutic formulations for oral administration. The microorganisms that colonize the oral cavity, their role in oral health and disease, as well as the probiotics and postbiotics which could have beneficial effects in this complex environment were discussed. The aim of this study was to review, analyse and discuss novel probiotic and postbiotic formulations intended for oral administration that could be of great preventive and therapeutic importance. A special attention has been put on the formulation of the pharmaceutical dosage forms that are expected to provide new benefits for the patients and technological advantages relevant for industry. An adequate dosage form could significantly enhance the efficiency of these products.
引用
收藏
页数:14
相关论文
共 21 条
  • [1] Formulation strategies for the oral delivery of probiotics: a review
    Thakur, Ajay Kumar
    Singh, Inderbir
    [J]. BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2019, 9 (05): : 4327 - 4333
  • [2] Emerging mycotoxins and preventive strategies related to gut microbiota changes: probiotics, prebiotics, and postbiotics - a systematic review
    Lazaro, Alvaro
    Vila-Donat, Pilar
    Manyes, Lara
    [J]. FOOD & FUNCTION, 2024, 15 (18) : 8998 - 9023
  • [3] Formulation strategies for drug delivery of tacrolimus: An overview
    Patel, Pranav
    Patel, Hitesh
    Panchal, Shital
    Mehta, Tejal
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2012, 2 (04) : 169 - 175
  • [4] Formulation Strategies of Nanosuspensions for Various Administration Routes
    Pinar, Sila Gulbag
    Oktay, Ayse Nur
    Karakucuk, Alptug Eren
    Celebi, Nevin
    [J]. PHARMACEUTICS, 2023, 15 (05)
  • [5] Biofertilizers in agriculture: An overview on concepts, strategies and effects on soil microorganisms
    Macik, Mateusz
    Gryta, Agata
    Frac, Magdalena
    [J]. ADVANCES IN AGRONOMY, VOL 162, 2020, 162 : 31 - 87
  • [6] An overview of probiotics, prebiotics and synbiotics in the functional food concept: Perspectives and future strategies
    Ziemer, CJ
    Gibson, GR
    [J]. INTERNATIONAL DAIRY JOURNAL, 1998, 8 (5-6) : 473 - 479
  • [7] Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin
    Kesharwani, Siddharth S.
    Mallya, Pooja
    Kumar, Vadikari Arun
    Jain, Vikas
    Sharma, Swagat
    Dey, Surajit
    [J]. AAPS PHARMSCITECH, 2020, 21 (06)
  • [8] Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin
    Siddharth S. Kesharwani
    Pooja Mallya
    Vadikari Arun Kumar
    Vikas Jain
    Swagat Sharma
    Surajit Dey
    [J]. AAPS PharmSciTech, 21
  • [9] An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery
    Madani, Faten
    Hsein, Hassana
    Busignies, Virginie
    Tchoreloff, Pierre
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2020, 25 (02) : 133 - 148
  • [10] Bifidobacterium animalis subsp. lactis HN019 live probiotics and postbiotics: production strategies and bioactivity evaluation for potential therapeutic properties
    D'ambrosio, Sergio
    Dabous, Azza
    Sadiq, Saba
    Casillo, Angela
    Schiraldi, Chiara
    Cassese, Elisabetta
    Bedini, Emiliano
    Corsaro, Maria Michela
    Cimini, Donatella
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12